Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

1.09
Delayed Data
As of Jul 29
 0.00 / 0.00%
Today’s Change
0.91
Today|||52-Week Range
7.60
-76.04%
Year-to-Date
Alkermes (ALKS) Posts Narrower Q2 Loss, Ups 2016 Outlook
Jul 29 / Zacks.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content
Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
Jul 28 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Label Expansion Under U.S., EU Review
Jul 19 / Zacks.com - Paid Partner Content
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Jul 26 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Zafgen Halts Development of Beloranib, to Cut Jobs by ~34%
Jul 20 / Zacks.com - Paid Partner Content
Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
Jul 18 / Zacks.com - Paid Partner Content